Showing 1541-1550 of 1841 results for "".
- American Academy of Optometry Foundation Announces 2019 Fredric Rosemore Low Vision Educational Grant Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-2019-fredric-rosemore-low-vision-educational-grant-recipient/2476860/The American Academy of Optometry Foundation (AAOF), in collaboration with the Fredric and Marion Rosemore Family Foundation, has announced that So-Yeon Sharon Lee, OD, FAAO, Dipl-ABO, was named the 2019 recipient of the Fredric Rosemore Low Vision Educational Grant. Dr. Lee is an Assistan
- BostonSight Announces Leadership Changes to Advance Ocular Surface Care Worldwidehttps://modernod.com/news/bostonsight-announces-leadership-changes-to-advance-ocular-surface-care-worldwide/2485722/BostonSight announced a 5-year strategic roadmap designed to redefine ocular surface treatment through advancements in clinical research, professional education, and specialty lens technology. As part of the plan, BostonSight announced a new leadership structure ai
- Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi Inc.https://modernod.com/news/eyenovia-announces-rebranding-and-corporate-name-change-to-hyperion-defi-inc/2482871/Eyenovia announced a rebrand to Hyperion DeFi Inc., signaling a pivot toward decentralized finance. The rebranding reflects Hyperion DeFi’s cryptocurrency treasury reserve strategy, centered around HYPE, the native token of the Hyperliquid block
- TearLab Announces Corporate Name Change to Trukera Medical; Targets Corneal Healthhttps://modernod.com/news/tearlab-announces-corporate-name-change-to-trukera-medical-targets-corneal-health/2481067/TearLab announced that it will be expanding its position in corneal health under the new name Trukera Medical. The rebranding reflects the company’s vision and future growth strategy targeting a broader set of unmet needs across corneal health. “We continue to rema
- NIH Study Classifies Vision Loss and Retinal Changes in Stargardt Diseasehttps://modernod.com/news/nih-study-classifies-vision-loss-and-retinal-changes-in-stargardt-disease/2480590/National Eye Institute researchers developed and validated an artificial-intelligence-based method to evaluate patients with Stargardt. The method quantifies disease-related loss of light-sensing retina cells, yielding information for monitoring patients, understanding genetic causes of the disea
- Holland Foundation for Sight Restoration Launched to Provide Life Changing Eye Surgerieshttps://modernod.com/news/holland-foundation-for-sight-restoration-launched-to-provide-life-changing-eye-surgeries/2479402/Edward Holland, MD, a pioneering ophthalmologist in the treatment of Severe Ocular Surface Disease, today announced the launch of the Holland Foundation for Site Restoration with a goal of establishing Centers of Excellence (COEs) throughout the country that would specialize in site restoration p
- Icahn to Push for Changes at Bausch Health After Disclosing Stakehttps://modernod.com/news/icahn-to-push-for-changes-at-bausch-health-after-disclosing-stake/2478869/Activist investor Carl Icahn disclosed in a regulatory filing that he has accumulated a 7.8% stake in Bausch Health, making him the largest single shareholder in the company. According to the filing, Icahn believes Bausch shares are “undervalued,” and that he plans to “engage in
- COVID-19 Clinical and Surgical Protocols: Which Changes Are Here to Stay?https://modernod.com/news/covid-19-clinical-and-surgical-protocols-which-changes-are-here-to-stay/2479512/
- House Telehealth Leaders Move to Cement Regulatory Changes for Virtual Carehttps://modernod.com/news/house-telehealth-leaders-move-to-cement-regulatory-changes-for-virtual-care/2478044/Leaders of the House telehealth caucus introduced legislation Thursday to permanently open up access to telehealth services for Medicare patients, according to a FierceHealthcare
- Mynosys Changes Name to Centricity Vision; Names New Leadership Teamhttps://modernod.com/news/mynosys-changes-name-to-centricity-vision-names-new-leadership-team/2477834/Centricity Vision, formerly known as Mynosys Cellular Devices, announced a new executive leadership team, along with a new company name. Centricity Vision reflects the company’s core competency, embodied by its Zepto Precision Cataract Surgery Platform, in creating precise, consistent, vis